A JAK2 mutation can make your body produce too many blood cells. JAK2 mutations are linked to blood cancers like polycythemia vera and other disorders. Some JAK2 mutations might be linked to Crohn's ...

The Janus kinase 2 (JAK2) protein mediates signaling from several cytokine receptors in the regulation of hematopoiesis and immune responses. Somatic mutations in human JAK2 lead to constitutive ...

The history of primary myelofibrosis dates back to 1951 and the description of four distinct clinicopathologic entities that came to be known as myeloproliferative neoplasms (MPNs): chronic myeloid ...

Impact of prior exposure to erythropoiesis-stimulating agents (ESA) on thromboembolic events in patients with myelodysplastic syndromes receiving luspatercept: A real-world TriNetX-based study. This ...

While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for ...

Treatment with programmed cell death 1/programmed cell death ligand 1 inhibitors for Kaposi sarcoma: A systematic review and meta-analysis. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...

JAK2 V671F poster presentation showcases potential best-in-class properties, including improved selectivity compared with currently approved ...

For over a decade, Ruth has written for multiple outlets providing patient education, including Health. She has written for health student education companies, collaborating on an anatomy textbook ...

Mutant blood cells that accumulate silently in bone marrow as people age can sharply raise the risk of coronary heart disease ...